Twist Bioscience, a company focused on synthetic DNA, today announced the completion of a $37 million Series C financing. Led by Illumina, Inc., participants in the round include new investors Fidelity Management and Research Company and Foresite Capital Management LLC, as well as all existing investors including Nick and Joby Pritzker (through their family’s firm Tao Invest), ARCH Venture Partners, Paladin Capital Group, Yuri Milner, and additional strategic corporate and venture investors.
PhishMe® Inc., the leading provider of phishing threat management solutions that empower employees to be a layer of human security sensors against phishing, malware, and drive-by attacks, today introduces PhishMe Triage, a new product offering that gives incident responders the analytics and visibility into email-based attacks occurring against their organizations in near real-time.
PhishMe® Inc., the leading provider of phishing threat management solutions that empower employees to be a layer of human security sensors against phishing, malware, and drive-by attacks, today announced it has raised $13 million in Series B funding led by existing investor Paladin Capital Group and new investor Aldrich Capital Partners.
ProtectWise Emerges from Stealth with More than $17 Million in Funding to Launch World’s First Cloud Network DVR for Enterprise Security
ProtectWise exits stealth today to launch a breakthrough cloud-based architecture poised to change the landscape of enterprise network security. ProtectWise leverages cloud economies of scale to deliver a subscription-based service that eliminates blind spots in threat detection, ends alarm fatigue by identifying and prioritizing network threats, and delivers faster and more effective incident response.
Bugcrowd Raises $6 Million In Series A Funding To Further Accelerate Enterprise Adoption Of Crowdsourced Security
Bugcrowd, the innovator in crowdsourced security testing for the enterprise, today announced it has raised $6 million in a Series A funding round led by Costanoa Venture Capital. Costanoa is joined by existing investors including Rally Ventures, Paladin Capital Group, and Blackbird Ventures.
10X Genomics today launched the GemCode™ Platform at the 16th annual Advances in Genome Biology and Technology (AGBT). The GemCode Platform is a unique molecular barcoding and analysis platform that consists of instrumentation, reagents and software, which delivers long range information, including haplotype phasing, structural variation, and de novo assembly.
Paladin Capital Group has completed a successful exit of its 49.9% ownership stake in Guardian Lima Holdings, a joint venture of a 60 million gallon per year biofuel production facility located in Lima, Ohio. Paladin’s stake in the joint venture was purchased by Guardian Energy Holdings, the 50.1% owner and strategic partner in the joint venture. With the closing of the transaction, Guardian Energy now owns 100% of the facility.
Good Harbor Security Risk Management, a premier cybersecurity advisory firm, announced today that it has appointed Rob Knake, former White House cybersecurity director and a leading expert in cybersecurity policy issues, as a senior advisor to the firm.
10X Genomics, a provider of an innovative genomics platform, today announced that it has raised $55.5 Million in its Series B financing. Foresite Capital Management led the B round and was joined by the Series A lead, Venrock, as well as new and existing investors, including Paladin Capital Group and funds managed by Morgan Stanley Investment Management. To date, the company has raised a total of more than $80M.
Advertisers will lose $6.3 billion globally to bots in 2015 The ANA partnered with White Ops, a security company with experience eradicating ad fraud on an initiative to determine the level of bot fraud occurring across the digital advertising industry. The ANA...